Clywedog reports final Phase Ib trial results for balomenib

Clywedog Therapeutics has reported final results from a Phase Ib trial of its investigational oral drug balomenib in adults with type 2 diabetes, with reductions in HbA1c and fasting plasma glucose maintained after treatment ended. The post…

Summary from Clinical Trials Arena.

Coverage 1 article · 1 outlet

1. Clinical Trials Arena 5h ago
   Clywedog reports final Phase Ib trial results for balomenib ↗